Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-19

Clinical Trial Update: B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on B244 Topical Spray for pruritus in adults with a history of atopic dermatitis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • B244 Topical Spray

Snippet

Sponsor: AOBiome LLC | Conditions: Atopic Dermatitis, Pruritus | Phase 2 | Status: COMPLETED | Results posted: 2024-12-19